Thyroid function in major thalassemia patients: Is it related to height and chelation therapy?

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3766932)

Published in Caspian J Intern Med on January 01, 2011

Authors

Peiman Eshragi1, Ahmad Tamaddoni, Khadijeh Zarifi, Amir Mohammadhasani, Majid Aminzadeh

Author Affiliations

1: Non-Communicable Pediatric Diseases Research Center, Amirkola Hospital, Babol University of Medical Sciences, Babol, Iran.

Articles cited by this

Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol (2006) 1.57

Role of deferiprone in chelation therapy for transfusional iron overload. Blood (2003) 1.52

Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab (2006) 1.42

Hormonal changes in thalassaemia major. Arch Dis Child (1976) 1.36

Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord (2003) 1.33

Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr (2003) 1.15

Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematol (1992) 1.09

Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol (1997) 1.01

Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child (1983) 0.99

Advances in management of thalassemia. Indian J Pediatr (2009) 0.99

Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child (1994) 0.93

A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi Med (2008) 0.92

Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study. Pediatr Endocrinol Rev (2008) 0.91

Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran. East Mediterr Health J (2004) 0.91

TSH secretion in thalassemia. J Endocrinol Invest (1984) 0.79